Evidence map›Paper›PMID 26494841›Full record

ArticleHaematologica2016

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Hideki Nakasone, Bita Sahaf, Lu Tian, Tao Wang, Michael D Haagenson, Kelsi Schoenrock, Spenser Perloff, Christine E Ryan, Fang Wu, Stephen R Spellman and 4 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Hideki NakasoneDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Bita SahafDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA.
Lu TianHealth Research and Policy, Stanford University School of Medicine, CA, USA.
Tao WangCenter for International Blood and Marrow Transplant Research and Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael D HaagensonCenter for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Kelsi SchoenrockDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA.
Spenser PerloffDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA.
Christine E RyanDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA.
Fang WuDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA.
Stephen R SpellmanCenter for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Stephanie J LeeCenter for International Blood and Marrow Transplant Research and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jerome RitzDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
David B MiklosDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA dmiklos@stanford.edu.
Center for International Blood and Marrow Transplantation
Stanford University · USNational Marrow Donor Program · USFred Hutch Cancer Center · USHarvard University · USMedical College of Wisconsin · US

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
TUMOR SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN BONE MARROW TRANSPLANTATIONP01CA049605 · NCI · STANFORD UNIVERSITY · PI Robert S Negrin · 1989 to 2026
$73.3M
PB vs. BMU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2001 to 2010
$63.3M
Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host DiseaseP01CA142106 · NCI · DANA-FARBER CANCER INST · PI RITZ, JEROME · 2009 to 2019
$17.5M
Identification of Minor Histocompatibility AntigensK08HL069132 · NHLBI · STANFORD UNIVERSITY · PI MIKLOS, DAVID B. · 2002 to 2006
$647k
Microarray Analysis of H-Y Antibodies in Human TransplantationR21HL084318 · NHLBI · STANFORD UNIVERSITY · PI MIKLOS, DAVID B. · 2007 to 2008
$434k
NCI NIH HHS P01 CA049605NCI NIH HHS P01CA049605NCI NIH HHS P01 CA142106NCI NIH HHS U24 CA076518NCI NIH HHS U24-CA76518NHLBI NIH HHS 5U01HL069294NHLBI NIH HHS K08 HL069132NHLBI NIH HHS K08HL69132NHLBI NIH HHS R21 HL084318NHLBI NIH HHS U01 HL069294PHS HHS HHSH234200637015C
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationTissue DonorsAdolescentAdultAllograftsFemaleGraft vs Host DiseaseHumansH-Y AntigenIsoantibodiesMaleMiddle AgedH-Y antibodyH-Y AntigenIsoantibodiesallogeneic hematopoietic transplantationbone marrow transplantationgraft versus host disease (GVHD)HY antigensex mismatch transplantation

Identifiers

PMID26494841
PMCPMC4697905
OpenAlexW1801012648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.